Application of CRISPR-Cas9 to interrogate novel gene functions in cutaneous melanoma (2021)
- Authors:
- Autor USP: MATSUYAMA, LARISSA SATIKO ALCANTARA SEKIMOTO - FCF
- Unidade: FCF
- Sigla do Departamento: FBC
- DOI: 10.11606/T.9.2021.tde-23022022-155211
- Assunto: MELANOMA
- Keywords: CRISPR-Cas9; CRISPR-Cas9; IRF4; IRF4; Melanoma; Melanoma; SIN3B; SIN3B
- Agências de fomento:
- Language: Inglês
- Abstract: Melanoma accounts for 3% of skin neoplasms and is the leading cause of death from skin disorders worldwide. The high mortality rate associated with this disease stems from the high capacity of melanoma patients to develop metastases and treatment relapse with inhibitors of the MAPK signaling pathway (such as BRAF inhibitors), commonly used in melanoma therapy. Thus, the investigation of genes involved in the mechanisms of melanoma development is essential for new and more effective therapeutic strategies. Hence, we describe in this thesis two projects involving the genes SIN3B and IRF4 as possible biomarkers for cutaneous melanoma. Initially, through bioinformatics analyses performed by our group, an upregulation of SIN3B was found in metastatic melanomas. This result together with the understanding of SIN3B role in regulating gene expression and oncogenic transformation, prompted us to describe in this thesis some mechanisms by which SIN3B may influence melanoma development. We then sought to characterize the gene function using SIN3B-deleted cells, generated by the CRISPR-Cas9 methodology. Initially, we observed increased SIN3B expression in BRAF-mutant metastatic melanomas, where we noted that the long splicing variant of the gene (NM_001297595.1) was effectively prevalent in melanomas. Subsequently, we designed gRNAs between the exons 2 and 3 of the human SIN3B gene and engineered three knockout clones and three control clones (containing empty lentiCRISPRv2 plasmid) from different melanoma cell lines (SKMEL28, A2058, and A375). Through functional analyses, it was observed that the absence of the gene did not interfere in the proliferation of tumor cells; however, it led to a decrease in invasive properties. These results were verified by Boyden chamber assays and transcriptome analysis (total RNA sequencing of deleted cells), where a decrease in migration and motility pathways was observed.Additionally, a screening of synthetically lethal genes with SIN3B was performed with a genome wide CRISPR library. These results showed that USP7 and STK11 genes, which belong to the FoxO signaling pathway, were essential in SIN3B-depleted melanoma cells. Finally, through a collaborative project with the Wellcome Trust Sanger Institute, previous large-scale sequencing analyses demonstrated that deletion of the IRF4 gene was lethal for melanoma cells. Accordingly, we performed IRF4 silencing in vitro and noticed that the lack of IRF4 promotes cell death and apoptosis, independently of MYC and MITF, known in the literature to be downstream targets of this gene. Therefore, these data suggest that IRF4 plays a vital role in melanoma cell survival. Taken together, both works herein described in this thesis demonstrate how CRISPR-Cas9 can be applied to study the functions and mechanisms of genes involved in melanoma progression, collectively helping in the development of more effective therapeutic strategies for this tumor
- Imprenta:
- Data da defesa: 06.12.2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-sa
-
ABNT
MATSUYAMA, Larissa Satiko Alcântara Sekimoto. Application of CRISPR-Cas9 to interrogate novel gene functions in cutaneous melanoma. 2021. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-23022022-155211/. Acesso em: 28 dez. 2025. -
APA
Matsuyama, L. S. A. S. (2021). Application of CRISPR-Cas9 to interrogate novel gene functions in cutaneous melanoma (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9142/tde-23022022-155211/ -
NLM
Matsuyama LSAS. Application of CRISPR-Cas9 to interrogate novel gene functions in cutaneous melanoma [Internet]. 2021 ;[citado 2025 dez. 28 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-23022022-155211/ -
Vancouver
Matsuyama LSAS. Application of CRISPR-Cas9 to interrogate novel gene functions in cutaneous melanoma [Internet]. 2021 ;[citado 2025 dez. 28 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-23022022-155211/ - Avaliação da terapia fotodinâmica em cultivo celular tridimensional de melanoma humano
- Development of epidermal equivalent from electrospun synthetic polymers for In vitro irritation/corrosion testing
- Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages
- Role of annexin A1 on pioglitazone mediated anti-inflammatory effects on experimental ulcerative colitis
Informações sobre o DOI: 10.11606/T.9.2021.tde-23022022-155211 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
